Milliporesigma To Become First Provider To Offer Fully Integrated Mrna Services

By Author: Orson Amiri
Total Articles: 410
Comment this article

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, has become the first Contract Testing, Development, and Manufacturing Organization (CTDMO) to offer integrated services for all critical stages of mRNA development, manufacturing, and commercialization. They have opened two GMP-grade mRNA drug substance manufacturing sites in Germany, part of their €1 billion investment in mRNA technologies. This investment also includes acquisitions like AmpTec and Exelead. These sites will provide mRNA services at all scales and applications, from pre-clinical to commercial, streamlining processes and speeding up clients' time-to-market. MilliporeSigma's expertise and product portfolio in mRNA, lipids, LNP, and more are offered globally to advance mRNA-based therapies, with applications ranging from cancer treatment to muscular dystrophy.

Read More - https://www.techdogs.com/tech-news/pr-newswire/milliporesigma-to-become-first-provider-to-offer-fully-integrated-mrna-services